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Summary 
Activation  of  resting  human  CD4 +  "naive"  (CD45RA+CD45RO -)  and  "memory" 
(CD45RA-CD45RO +) T cells requires costimulatory signals in addition to engagement of the 
T  cell receptor/CD3 complex (TCR/CD3).  The adhesion pathways  mediated by lymphocyte 
function-associated antigen 1/intercellular adhesion molecule 1 (LFA-1/ICAM-1) and CD2/LFA-3 
are capable of providing such costimulatory signals. Our work shows that these costimulatory 
adhesion pathways are critically involved in regulation ofT cell differentiation/maturation. Evidence 
for subset-specific costimulatory requirements is demonstrated by the finding that only memory 
CD4 + T  cells were costimulated by LFA-3,  whereas  both naive and memory CD4 + T  cells 
were costimulated by ICAM-1. In addition, these costimulatory adhesion pathways regulated 
reciprocal cytokine secretion patterns for interleukin 5 (IL-5) and granulocyte/macrophage  colony- 
stimulating factor (GM-CSF). Repeated costimulation of CD4 + memory T cells with LFA-3 
led to secretion of high levels of IL-5, while repeated costimulation with ICAM-1 induced high 
levels of secreted GM-CSF. Significant interferon 3' (IFN-'y) production was observed with either 
of the costimulatory ligands. Extensive cell surface analysis of these in vitro cultures of peripheral 
blood derived memory CD4 §  T  cells, with  monoclonal antibodies obtained from the 5th 
Leucocyte Typing Workshop, revealed differential expression of a singular antigen, CD60. This 
antigen was preferentially expressed on LFA-3-costimulated cells suggesting a positive correlation 
between CD60 expression and a T helper type 2-like cytokine profile. In conclusion, this report 
demonstrates a new functional role for costimulatory adhesion molecules in regulating differential 
cytokine secretion in human memory CD4 + T  cells. 
V 
arious T  cell accessory molecules have been shown to 
be capable of providing costimulatory signals required 
for T cell proliferation (1-8).  Many of these costimulatory 
molecules are also involved in adhesive interactions of the T 
cells with apposing cells and extracellular matrix components 
(9-12). These shared adhesive properties have raised the ques- 
tion as to (a) whether a common intracellular signal is in- 
volved in the action of these costimulatory adhesion pathways 
(13); and (b) what might be the in vivo relevance of these 
seemingly redundant multiple T cell costimulatory pathways. 
We and others have proposed models predicting that the 
unique microenvironment of the site of antigen presentation 
will influence the differentiation/maturation of T cells into 
distinct functional effector populations upon antigen-specific 
stimulation (8,  14-18).  In particular,  the locally  available 
costimulatory pathways, ECM proteins, and cytokines may 
provide the specific combinatorial set of signals necessary for 
the development of specialized immune responses. 
In this study we address, in a simplified in vitro model 
system, some of these issues by investigating the costimula- 
tory role of adhesion molecules intercellular adhesion molecule 
1 (ICAM-I*; CD54) and leukocyte function-associated an- 
tigen 3 (LFA-3; CD58) in mature T cell activation and differen- 
tiation. We studied the activation requirements of human 
resting  "naive"  (CD45KA §  and  "memory" 
1  Abbreviations used in this paper: ICAM-1, intercellular  adhesion  molecule 
1; Thp, T helper precursors. 
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Differentiation into distinct effector populations was exam- 
ined by determining the levels in the culture supernatants 
of the various cytokines e.g., IL-5, IFN-3', and GM-CSF, after 
TCR/CD3-mediated activation with these multiple costimula- 
tory conditions. FACS  ~ analysis was simultaneously performed 
on the CD4 § T  cells derived from these in vitro cultures. 
Our findings showed subset specific  requirements for costimu- 
lation by ICAM-1 and LFA-3. Furthermore,  repeated costimu- 
lation of memory CD4 + T  cells led to reciprocal  cytokine 
profiles for IL-5 and GM-CSF, and differential expression  of 
the ganglioside antigen GD3 (CD60). These combined results 
demonstrate the role of costimulatory adhesion molecules in 
regulation of T  cell differentiation. 
Materials and Methods 
Cells.  Human PMBCs from normal donors were separated  by 
Ficoll-Hypaque  density-gradient  centrifugation. Resting CD4 + T 
cells were subsequently obtained by rigorous immunomagnetic 
negative selection with Advanced Magnetic Particles (Advanced 
Magnetic, Cambridge, MA) bound to goat anti-mouse IgG. Nega- 
tive selection was performed as described (20), using a cocktail of 
mAbs consisting of anti-HLA class II mAb (IVA12), CD19 mAb 
(FMC 63), CD16 mAb (3G8), CDllb mAb (NIH11b-1), CD14 
mAb (63D3), CD8 mAb (B9.8), and mAb against glycophorin 
(10F7). For isolation of the reciprocal subsets of CD45RO + and 
CD45RA + CD4 + T cells the CD45RA mAb (FMC71) and the 
CD45RO mAb (UCHbl), respectively,  were added to the cock- 
tail of mAbs. Purity of the isolated cells was >98%. The selected 
CD4 + T ceils were free of monocytes based on the criterion that 
there is no proliferative  response to optimal concentrations (1/200 
dilution) of PHA (M form) (GIBCO BILL, Gaithersburg, MD). 
Proliferation  Assays.  Proliferation assays  were performed using 
standard techniques  as described (1). Briefly  50,000 purified CD4 + 
T cells/microtiter  well were cultum:l  in 96-weU tissue  culture clusters 
with flat bottom wells (model no. 3596; Costar Corp., Cambridge, 
MA) for 3 d in culture medium (KPMI 1640 supplemented with 
20 mM glutamine, 10% heat-inactivated FCS, and 100 IU/ml of 
penicillin, 100/~g/ml  streptomycin  [all  from Biowhittaker,  Gaithers- 
burg, MD]) under various conditions as mentioned in the experi- 
ment description, and pulsed (25/~l/well) with a [3H]thymidine 
solution (5 mCi/ml, 2 mCi/mmol specific activity; New England 
Nuclear, Boston, MA) during the last 24 h before being harvested 
on glass fiber filters. Incorporation of radioactive label was mea- 
sured by liquid scintillation counting. Results are expressed as the 
arithmetic mean cpm of triplicate cultures. Monocyte-independent 
CD4 + T cell proliferation was obtained by stimulation with the 
combination of PMA (1 rig/m1) and PHA (1/200 dilution). For 
prolonged culture through repeated stimulation,  24-well  flat bottom 
tissue culture cluster plates (model no. 3524; Costar Corp.) were 
used. Restimulation of the cell cultures was performed 6 d after 
the last stimulation. 
Antibody Reagents  and Other Reagents.  mAbs  were used as dilu- 
tions of ascites fluid unless indicated otherwise in the following 
list. CD3 mAb: murine derived  mAb mOKT3 (IgG2a) (American 
Tissue Culture Collection [ATCC], Rockville, MD)  and a hu- 
manized version hOKT3 (CDR grafted on human IgG4 with ala- 
nine substitutions in its Fc-receptor binding site (21) (both used 
as purified immunoglobulin) (Dr. J. A. Bluestone, University of 
Chicago); anti-HLA class II mAb: IVA12 (IgG1) (Dr. J. D. Capra, 
University of Texas Southwestern Medical Center, Dallas, TX); 
CD19 mAb; FMC63 (IgG2a) (Dr. H. Zoh, Flinders  Medical  Centre, 
Bedford  Park, South Australia); CD16 mAb; 3G8 (IgG1) (Dr. D. M. 
Seal, National Cancer Institute, Bethesda, MD); CD14 mAb: 63D3 
(IgG1) (Dr. J. D. Capra); glycophorin mAb: 10F7 (ATCC); CD8 
mAb: B9.8 (Dr. B. Malissen, Institut National de la Sant~ et de 
la R~herche Medicale-Centre  National de h Recherche  Seientifique 
[INSERM-CNRS], Marseille, France); CD45RA mAb: FMC71 
(IgG2b) (Dr. H. Zola); CD45RO mAb: UCHL-1 (Dr. P. Beverley, 
Imperial Cancer  Research Fund,  London,  UK),  CD60  mAb: 
UM4D4 (IgM) (Dr. D. Fox, University of Michigan, Ann Arbor, 
MI), and T cell panel of the 5th Leukocyte Typing Workshop. 
Aflfinity-purified  ICAM-1 was isolated from a Hodgkin's lym- 
phoma cell line, L428, as described  (1). Aflfinity-purified  multimeric 
LFA-3 is isolated  from red blood cells as described (22). The purified 
proteins ICAM-1, LFA-3,  and the CD3 mAbs mOKT3 and hOKT3 
were immobilized on the plastic well bottom by dilution in PBS. 
After overnight incubation at 4~  wells were washed with PBS. 
The amount of purified protein applied to each well is indicated 
in the figures. 
Mitogen-driven T cell activation was performed with PHA-M 
(GIBCO-BRL) at 1/200 final dilution and phorbol ester PMA at 
1 ng/ml. 
Recombinant human Iblfl and Ib4 were purchased from Col- 
laborative Biomedical  Products (Becton Dickinson Labware, Bed- 
ford, MA) and recombinant human Ib2, Ib6, and IL-7 were pur- 
chased from GIBCO-BRL. 
Cytokine Assays.  To obtain culture supernatant  for cytokine  anal- 
ysis the cells were cultured in culture medium (see above) (10 6 
cells/ml, final  volume 2 ml) in 24-well flat bottom tissue culture 
plates (model no. 3524; Costar Corp.). Preparation of the tissue 
culture plates were identical to those used for proliferation and 
prolonged cultivation through repeated restimulation. The culture 
supernatants were harvested 24 or 48 h after (re)stimulation of the 
cells. IL-4, GM-CSF, IL-5, and IFN-y levels in those experiments 
indicated with the letter "A:' as depicted in Table 1, Figs. 2 and 
3 (e.g., Exp. 1 A and 2 A) were determined in ELISA assays as 
described (23); minimum sensitivities  of those assays  were >1 ng/ml 
for GM-CSF, >30 pg/ml for II_,5 and ;>0.1 ng/ml for IFN-y. The 
levels of GM-CSF, and IL-5 in the culture superuatants of those 
experiments indicated with the letter "B", as depicted in Figs. 2 
and 3 (e.g., Exp. 1 B and 2 B) were determined using commercially 
available mAb based ELISA assays (PharMingen, San Diego, CA) 
and performed according to the suppliers instructions. Minimum 
sensitivities of these assays  were >1 ng/ml for GM-CSF, and >75 
pg/ml for IL-5. Levels of IFN-y in the "B" series of experiments 
were determined with an ELISA  assay  developed in our laboratory 
using a human IFN-y-specific mouse mAb and a human IFN- 
V-specific rabbit antiserum, both purchased from Biosource Inter- 
national (Camarillo, CA). Goat anti-rabbit horseradish  peroxidase 
(HRP) with specific substrate was used for readout. The sensitivity 
for IFN-y detection was >0.1 ng. 
Flow Microfluorometry.  Cells  (3-4  x  10  s) were washed with 
FACS  |  (Becton Dickinson & Co., Mountain View, CA) media 
(HBSS without phenol red and without Ca+/Mg  2+  [Biowhit- 
taker] containing 0.2% human serum albumin and 0.2% sodium 
azide) before incubation with human IgG (10 mg/ml) for 10 min 
at 4~  to inhibit subsequent binding of mAb to FcR. Cells were 
then incubated with specific mAb at saturating concentrations for 
30 min at 4~  washed twice with FACS  |  media, and stained  with 
FITC-conjugated f(ab')2 goat anti-mouse IgG (Southern Biotech- 
nology Associates, Inc., Birmingham, AL) for another 30 min at 
4~  Finally the cells were washed twice and analyzed using a 
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on a log scale. Histogram overlays  were made with the use of the 
flow analyze program  WinMDI provided through Internet by 
Joseph Trotter (The Salk Institute,  La Jolla,  CA). 
Results 
Differential Costimulatory Requirements  for Naive and Memory 
CD4 + T  Cells.  In our study of various costimulatory re- 
quirements of human subpopulations of CD4 + T  cells we 
used an adaptation of a previously described simplified cul- 
ture model for T cell activation (1). Briefly, a CD3 mAb (hu- 
manized OKT3,  see Materials and Methods) is coimmobi- 
lized with either of  the purified costimulatory adhesion ligands, 
ICAM-1, or LFA-3. These molecules, ICAM-1 and LFA-3, 
costimulate through interaction with receptors LFA-1(CDlla/ 
CD18) and CD2 on the T cell, respectively. Highly purified 
populations of resting CD4 +  CD45RA +  CD45RO-  (naive) 
and  CD4 +CD45RA-CD45RO +  (memory) T  cells,  ob- 
tained through rigorous negative-selection, were stimulated 
in this model in a 4-d proliferation assay. The in vitro culture 
conditions  included  the  addition  of human  recombinant 
cytokines at the start of the culture. The proliferation results 
of four representative experiments are shown in Fig.  1, A 
and B. Immobilized CD3 mAb alone or in combination with 
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Figure  1.  Differential costimulation of 
naive and  memory  CD4 +  T  cells  with 
ICAM-1 and LFA-3. (A) Naive CD4 + T 
cells, (B) Memory CD4*  T cells. Human 
CD4 + T cells were isolated (see Materials 
and  Methods)  and  stimulated  in  a  4-d 
proliferation assay with CD3 mAb alone 
(1/~g/ml), CD3 mAb  +  ICAM-1 ("250 
ng/ml) or CD3  +  LFA-3 (2/~g/ml) in the 
presence of various cytokines such as rib1/ 
rIL-6, rib2, rib4, and rib7 at a final con- 
centration of 10 U/ml. Murine OKT3 was 
used for donors 308,  310,  311, and hu- 
manized OKT3 for donor 1061. the various cytokines (rlL-1/6, rlL-2, rlL-4, and rlL-7) did 
not lead to proliferation of naive cells (Fig.  1 A) and only 
minimal proliferation with memory cells (Fig. 1 B). ICAM-1 
costimulation induced proliferation both in naive and memory 
cells.  In  some donors  naive  cells  required  the  addition  of 
cytokines to achieve  strong proliferation  (donors  1061 and 
311; Fig. 1 A). The results with rlL-1/6 and rlL-2 confirm 
previous published observations (2). 
It is interesting to note that costimulation with LFA-3 was 
restricted to the memory cells.  Addition of the exogenous 
cytoldnes rlL-1/6 and rlL-2 consistently enhanced this prolifer- 
ation (Fig.  1 B), whereas a lesser effect was observed after 
addition  of rlL-4 and rlL-7  in these assays. 
Naive and Memory CD4 + T  Cells Have Different Cytokine 
Profiles.  To investigate whether different costimulatory con- 
ditions may result in generation of distinct effector functions 
we tested the cytokine profiles of the two subpopulations 
of human CD4 + T  cells after costimulation with ICAM-1 
or LFA-3. Supernatant  was collected after 24 h of stimula- 
tion  and assayed for the presence of a variety of cytokines 
(Table  1); cell proliferation  (day 4) in parallel  cultures was 
also determined.  The results indicated that naive cells pro- 
duce significant amounts of IL-2, but fail to secrete detect- 
able levels of IL-4, IFN-% or GM-CSF (Table  1).  Further- 
more, IL-2 production correlated with subsequent prolifera- 
tion  of naive cells,  and was only observed with  ICAM-1. 
Memory CD4 + T  cells  differed in producing  not  only 
more IL-2, but also significant levels of IFN-3' and GM-CSF 
(Table 1). Occasionally, even low levels of IL-4 could be de- 
Table  1.  Cytokine Profile of Naive and Memory CD4 + T  Cells 
tected. Primary stimulations of memory cells did not, how- 
ever, show a significant difference in the pattern of cytokine 
secretion between costimulation through ICAM-1 or LFA-3. 
Repeated  Costimulation  of Memory  CD4 +  T  Cells with 
ICAM-1 or LFA-3 Leads to Different Cytokine Profiles, Resem- 
bling Thl- and Th2-1ike Patterns.  The studies shown in Table 
1 were restricted to primary stimulations of resting cells. We 
subsequently performed studies on both naive and memory 
cells using repeated stimulations at 6-d intervals with the same 
costimulatory condition.  Initial experiments indicated that 
the addition  of rlL-2 to the cultures resulted far better cell 
yields after repeated stimulation than addition to the cultures 
of a combination of rlL-l~/rlL-6,  and that supernatant col- 
lected after 48 h was optimal  (data not  shown).  Less IL-2 
and IL-4 were detected in the culture supernatants  of sec- 
ondary and tertiary stimulations (after 24 and 48 h) than in 
primary stimulations suggesting a higher cytokine consump- 
tion rate.  Indeed 6 d  after each stimulation  cells expressed 
high levels of IL-2 receptor ol (CD25) (data not shown). There- 
fore, we focused on the cytokine IFN-% GM-CSF, and IL-5 
which (a) appeared unaffected by consumption and (b) whose 
secretion profiles would allow us to make comparisons with 
Thl-like and Th2-1ike cytokine patterns. The results shown 
for naive cells (Fig.  2, A  and B) are restricted  to repeated 
stimulations  with ICAM-1, because naive ceils fail to be stimu- 
lated by LFA-3.  Only the results for IFN-3~ and GM-CSF 
are shown, because IL-5 was not detectable under any condi- 
tion or at any time point in naive cell cultures. While naive 
cells did not produce much GM-CSF (Table  1,  and Fig.  2 
IL-2  IL-4  IFN-3'  GM-CSF  Proliferation 
U/ml  pg/ml  ng/ml  ng/ml  CPM/1,000 
24h  24h  24h  24h  96h 
Exp.  1A 
Exp.  2A 
Exp.  1A 
Exp.  2A 
Naive  CD4 § T  cells 
CD3 mAb  +  ICAM-1  +  rlL-1/6  8.4  <50  <0.1  <0.8  108.0 
CD3 mAb  +  LFA-3  +  riLl/6  <1.0  <50  <1.0  <0.8  0.1 
PHA/PMA  +  rIL-1/6  55.6  <50  1.6  <0.8  70.0 
CD3 mAb  +  ICAM-1  +  rlL-1/6  >87.0  <50  0.6  <0.8  57.0 
CD3 mAb  +  LFA-3  +  rlL-1/6  3.8  <50  0.2  <0.8  0.1 
PHA/PMA  +  rIL-1/6  >87.0  <50  5.7  1.2  83.0 
Memory CD4 § T  cells 
CD3 mAb  +  ICAM-1  +  rlL-1/6  59.9  96  2.1  17.2  96.0 
CD3 mAb  +  LFA-3  +  rlL-1/6  51.4  <50  2.1  2.7  43.0 
PHA/PMA  +  rlL-1/6  54.4  <50  1.8  2.0  55.0 
CD3 mAb  +  ICAM-1  +  rlL-1/6  >87.0  94  2.4  3.8  52.0 
CD3 mAb  +  LFA-3  +  rlL-1/6  >87.0  54  4.6  3.0  48.0 
PHA/PMA  +  rIL-1/6  >87.0  129  3.9  3.9  34.0 
Cytokine levels were determined in culture supernatants, 24 h after primary stimulation with CD3 mAb (murine OKT3)  +  ICAM-1 or CD3 mAb 
+ LFA-3, or PHA/PMA (as described  in Materials and Methods). Proliferation  data are from parallel cultures at day 4 (see Materials and Methods). 
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Figure 2.  Cytokine profiles  of 
naive CD4 + T cells after ICAM-1 
costimulation. (.4) GM-CSF, (B) 
IFN-% Culture supernatants were 
collected  48 h after each (re)stimula- 
tion. The level of cytokine  produc- 
tion was determined  in ELISA assay 
(see  Materials  and Methods). Costim- 
ulatory conditions of ICAM-1 are 
described in Materials and Methods. 
biD, Not detectable  above  background. 
A) or IFN-'y (Table 1 and Fig. 2 B) in the primary stimula- 
tions, they did produce significant levels of both cytokines 
after secondary and tertiary stimulation (Fig.  2, A  and B). 
The levels of GM-CSF produced by naive cells were com- 
parable to those of memory cells (Figs. 2 A and 3 C), whereas 
levels of IFN-3~ never reached those of memory cells (Figs. 
2 B and 3 B). Analysis on a FACScan  |  of these repeatedly 
stimulated naive cells showed that complete phenotypic conver- 
sion from CD45RA +  CD45RO-  to CD45RA- CD45RO + 
had taken place after the tertiary stimulation (data not shown). 
Most interestingly, repeated costimulation of memory cells 
with ICAM-1 or LFA-3 did lead to differential cytokine secre- 
tion. Specifically, the levels for IL-5 produced dearly showed 
a positive correlation with LFA-3 costimulation (Fig. 3 A). 
In contrast, GM-CSF levels produced were markedly higher 
with ICAM-1 costimulated memory cells (Fig. 3 C). IFN-3, 
was  only  marginally  higher  with  ICAM-1  costimulated 
memory cells  (Fig.  3 B). 
Repeated  Costimulation  of Memory  CD4 +  T  Cells with 
ICAM-I or LFA-3 Leads to Phenotypically Different Cell Popu- 
lations as Defined by the Cell Surface Molecule CD60.  To es- 
tablish whether different costimulatory in vitro culture con- 
ditions influence the phenotype of the stimulated cells we 
performed FACScan  |  analysis  with a large series of mAbs 
including the T cell panel of mAbs from the Fifth Leukocyte 
Typing Workshop. We specifically focused on memory cells 
in the hope of identifying staining patterns that might correlate 
with the differential cytokine profiles observed when memory 
cells are repeatedly stimulated with ICAM-1 or LFA-3. From 
a panel of over 90 different mAbs only one mAb showed con- 
sistently a  different staining  pattern.  The  mAb  UM4D4 
(CD60-specific) stained resting CD4 + memory T cells in a 
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bimodal pattern (40-60% positive cells) (Fig. 4, A  and D). 
After repeated costimulation with ICAM-1 only very low 
levels of CD60-positive cells could be found (Fig. 4, B and 
E). In contrast, memory cells repeatedly costimulated with 
LFA-3 maintained significant levels of CD60 expression cells 
(Fig. 4, C and F). Resting naive cells are negative for CD60 
and repeated stimulation of naive cells with ICAM-1 did not 
affect this staining pattern (data not shown). 
Discussion 
This  study was  initiated  to  determine the  role of the 
costimulatory adhesion pathways LFA-1/ICAM-1 and CD2/ 
LFA-3 in human T cell activation and differentiation/matu- 
ration. The function of accessory molecules in T cell activa- 
tion and differentiation/maturation has been widely studied 
using a variety of approaches (reviewed in 15, 16). The de- 
sign of our present study is unique in several respects.  First, 
we have used natural ligands, rather than mAbs, to study 
the contribution of costimulatory adhesion pathways in iso- 
lation. Second, the T cells used in our experiments are highly 
purified,  and  comparisons  are  made  between  two  well- 
established functionally distinct  subpopulations  of resting 
human CD4 + T cells, distinguished by their differential ex- 
pression of isoforms of the CD45 gene; specifically, we com- 
pared the CD45RA +  CD45RO-  subset, consisting of naive 
cells, and the CD45RA-CD45RO + subset, which includes 
putative memory cells. Third, we used a multifaceted approach 
to examine T cell activation and differentiation/maturation 
by analyzing not only cell proliferation and cytokine secre- 
tion patterns, but also the cell surface phenotype of the acti- 
vated cells. A  'Memory" CD4+ T  cells 
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Figure 3.  Cytokine profiles of memory CD4 + T cells 
after ICAM-1 or LFA-3  costimulation. (A) Ib5, (B) IFY-'y, 
and (C) GM-CSF. Culture supernatants  were collected  48 h 
after each (re)stimulation. The level  of IL-5, GM-CSF, and 
IFN-'y production was determined in ELISA assay (see 
Materials and Methods).  Costimuhtory conditions of 
ICAM-1 and LFA-3 are described in Materials and Me- 
thods. ND, Not detectable above background.  NT, Not 
tested. 
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Figure 4.  Differential CD60 expression after repeated costimulation of memory CD4 + T cells with ICAM-1 or LFA-3. Two representative donors 
are depicted in figure: donor A: (/1, B, and C); and donor B: (D, E, and F). Dotted  lines are negative control anti-CD19 mAb (FMC63) and solid 
lines are anti-CD60 mAb (UM4D4). (A and D) starting population at day 0 (resting cells); (B and E), ICAM-1 costimulated population day 14 (2 d 
after tertiary stimulation). The percentage CD60 + cells is 15% in (B) and 8% in (E); (C and F), LFA-3 costimulated  population day 14. The per- 
centage CD60 + cells is 51%  in (C) and 27%  in (F). 
The proliferation  studies described in Fig.  1 (/1  and B) 
showed the surprising finding that only memory CD4 + T 
cells can be costimulated with natural ligand for CD2, LFA-3, 
while both naive and memory CD4 + T cells readily respond 
to costimulation with ICAM-1, the natural ligand for LFA-1. 
Several possibilities exist for the lack of response of naive cells 
to LFAo3 costimulation including an inadequate interaction 
with the ligands and/or absence of cofactors in the intracel- 
lular signal transduction pathways. Naive CD4 + T cells ex- 
press less of the specific receptor CD2 than memory CD4 + 
T  cells (24). Nevertheless both naive and memory T  cells 
can be isolated from PBL by E-rosetting,  which is predomi- 
nantly an adhesive interaction  through CD2/LFA-3, indi- 
cating at least a certain degree of functional binding through 
CD2 occurring in both subsets. It was recently shown that 
the avidity of CD2 for LFA-3, in analogy with integrins, 
is also upregulated by TCR/CD3 complex-mediated activa- 
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tion (25). One can, therefore, suggest that naive CD4 + T 
cells may not have the requirements to obtain a high avidity 
CD2 receptor. Indeed, in studies with coimmobilized CD3 
and CD2  mAbs,  both naive and memory CD4 + T  cells 
could be induced to proliferate (data not shown). This sug- 
gests that if one circumvents the issue of strength of interac- 
tion by using mAbs one can overcome the lack of responsive- 
ness in naive CD4 + T cells for LFA-3 costimulation.  These 
findings also demonstrate the distinct advantage of the usage 
of natural ligand in reproducing in vivo stimulatory condi- 
tions. In addition to LFAo3, there are two alternative (low 
afhnity) ligands for CD2, namely CD59 (26-28) and CD48 
(29-32). Deckert et al. (26) reported that CD59 showed both 
synergy in CD2-mediated adhesion and activation of T cells 
using LFA-3 and CD59 transfectants (26). We, however, were 
unable to confirm any stimulatory effect of purified CD59 
(kindly provided by Dr. P. Sims, Milwaukee Blood Center, Milwaukee, WI) alone or in combination with LFA-3 in our 
in vitro system. For optimal adhesion and activation of T 
cells through these ligands of CD2 one may need sufficient 
lateral mobility of these ligands (33), which can more easily 
be achieved in cell transfectants. 
Human CD4 § T cells, by analogy to the murine system 
(34, 35), can be divided into at least four functional subsets: 
Thp, Th0, Thl, and Th2, based on their pattern of cytokine 
secretion (36-40). The T helper precursors (Thp) are mainly 
limited to the production of IL-2. Activated Thp cells most 
likely differentiate initially into Th0-1ike cells (41) producing 
IL-2, IL-4, and GM-CSF, but not TNF-B or IL-5. Subse- 
quent maturation can either lead to Thl-like cells secreting 
cytokines including IL-2, IFN-y, TNF-B, and GM-CSF or 
Th2-1ike  cells capable of producing IL-4, IL-5,  IL-IO, and 
low levels of GM-CSF (34, 36,  38,  40,  42). In contrast to 
the mouse, human Thl-like cells appear to secrete low levels 
of IL-10 (43).  Thl-like cells are in general associated  with 
delayed type sensitivity and cell-mediated immunity (44), while 
Th2-1ike cells are effective in assisting humoral responses (44). 
To assess differentiation/maturation upon costimulation with 
ICAM-1 or LFA-3 we focused initially on cytokine secretion 
patterns, which would help to distinguish these putative T 
helper subsets.  We found that naive CD4 + T cells predom- 
inantly secreted IL-2 in the primary stimulations (Table  1) 
and therefore resemble strongly a Thp-like population. This 
confirms data from other laboratories in other systems (16, 
45, 46).  The broad range of cytokines readily produced in 
a primary stimulation by memory CD4 + T  cells with ei- 
ther ICAM-1 or LFA-3 costimulation (Table 1) suggest, as 
expected, that memory cells contain a mixture of cell popu- 
lations with Th0- (i.e., IL-2, IL-4), Thl- (i.e., IL-2, IFN-3t), 
and Th2-1ike (i.e.,  IL-4,  IL-5) characteristics. 
Repeated stimulation, however, of  both naive and memory 
CD4 +  T  cells  led  to  distinct  different cytokine profiles. 
Naive cells were now capable of producing GM-CSF and 
IFN-3, (Fig. 2, A and B), although the secreted IFN-qt levels 
did not reach those of memory cells (Fig. 3 B). Most interest- 
ingly, memory CD4 + T cells showed costimulatory signal- 
dependent regulation of cytokine secretions patterns after 
repeated in vitro stimulation. ICAM-1 costimulation induced 
significant levels of  both GM-CSF (Fig. 3 C) and IFN-y (Fig. 
3 B), but only minor amounts of IL-5 (Fig.  3 A). In con- 
trast, LFA-3 costimulation led to high levels of IL-5 (Fig. 
3 A) and low levels of IFN-y (Fig.  3 B). The yield of GM- 
CSF, while substantial,  was still  significantly less than ob- 
tained with ICAM-1 costimulation (Fig. 3 C). These results 
indicate that LFA-3 costimulation of memory CD4 § T cells 
results  in  a  preferential Th2-1ike  pattern  (IL-5  and lower 
amounts of GM-CSF), while ICAM-1 cos'timulation gives 
rise to a Thl-like pattern (IFN-~ and high amounts of GM- 
CSF, no IL-5). The clearly detectable levels of IFN-y after 
LFA-3 costimulation differ from the usual Th2-1ike cytokine 
pattern. There are two possibilities  for the effect of LFA-3 
costimulation on IL-5 secretion: (a) direct regulation of IL-5 
secretion or (b) preferential outgrowth of Th2-1ike cells. We 
favor the latter hypothesis in which LFA-3-stimulated cells 
are gradually enriched for Th2-1ike  subset of cells, but may 
still contain some Thl-like cells. Evidence for heterogeneity 
among the LFA-3-costimulated cells can also be seen in the 
FACScan |  analysis of CD60 expression (Fig.  4, C  and F). 
Similarly, ICAM-1 costimulation could enrich for Thl-like 
cells. Others scenarios are certainly possible, as can be deduced 
from a recent publication from Schandene et al. (47), in which 
they found evidence for suppression of T cell IL-5 secretion 
by IL-10.  Our preliminary results show that IL-10  is pro- 
duced in (both) primary stimulations, but not thereafter (data 
not shown). One could therefore postulate that there is in- 
deed an inverse correlation between IL-IO and IL-5, but this 
is,  nevertheless, still  LFA-3 costimulation dependent. 
T cell differentiation/maturation was also examined by de- 
termining cell surface phenotype of the differentially stimu- 
lated cells. These cytofluorometric studies showed remark- 
able consistency of phenotype; with one singular exception, 
expression of the cell surface antigen CD60 on LFA-3-costimu- 
lated memory cells. The CD60 expression which is present 
on 40-60%  of the starting population of resting memory 
CD4 +  T  cells  is  almost  completely lost  after  ICAM-1 
costimulation. In contrast, LFA-3 costimulated cells main- 
tain significant levels of CD60 + cells. 
The CD60 antigen is expressed by a variety of different 
hematopoietic lineages,  such  as  T  cells,  monocytes,  and 
platelets.  Surface expression on T cells is restricted to subsets 
of CD4 + and CD8 + T cells. The CD60+CD4 § subset con- 
tains the cells that can provide help for B cell differentiation 
(48).  In  CD4 + T  cells,  IL-4 production  is higher in the 
CD60 § CD4 + subset, while the CD60- CD4 § cells secrete 
more IL-2  (49).  Similarly, CD60+CD8 + T  cells  produce 
the majority of the IL-4 and are able to drive B cell differen- 
tiation, whereas CD60-CD8 § T  cells secrete most of the 
IFN-3' (50).  The CD60 antigen has been identified as the 
O-acetylated disialosyl group which is expressed on ganglio- 
side GD3 (51). Differential membrane expression of glycolipids 
on Thl and Th2 cells has also been observed in mouse. Pres- 
ence of the ganglioside GDla was found restricted to Th2 
cells, whereas the ganglioside GDlc~ was found on Thl cells 
(52).  These combined results point to a distinct pattern of 
expression of various gangliosides correlating with Thl-like 
and Th2-1ike  cytokine profiles. 
A wide series of other cell surface markers has been sug- 
gested in the literature for identifying functional human T 
helper subsets including CD26 (53, 54), CD27 (55, 56), CD30 
(57),  and CD31 (58).  The panel of antibodies with which 
we screened for differential expression, after ICAM-1 or LFA-3 
costimulation, included at least two different mAbs directed 
against each of these markers, but yielded no differences in 
our hands. It should be mentioned, however, that cell sur- 
face expression of subset-specific  markers will be regulated 
both in vivo and in vitro by a variety of factors, such as acces- 
sory pathways, presence of cytokines and growth factors, and 
the downregulatory effects on receptor expression after in- 
teraction with their counter-receptor. 
The regulatory effects of cytokines such as IL-4 (39,  59, 
60),  IFN-y (59, 61, 62) and IL-12 (63-67) on T  helper cell 
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In contrast, up until now, there have been no reports describing 
the role of costimulatory adhesion ligands in this process of 
T helper cell differentiation/maturation.  Our studies are the 
first to demonstrate specific costimulatory adhesion pathway- 
dependent CD4 + T cell differentiation, both at the level of 
cytokine secretion and at the level of cell surface phenotype. 
Although  our results  establish  the  important  principle  of 
costimulatory  adhesion  pathway-dependent  CD4 +  T  cell 
differentiation, it is unclear under what physiological condi- 
tions  this might  operate.  Since IFN-3' is a potent  inducer 
of ICAM-1, this may be part of feedback by which Thl-like 
patterns are reinforced. Further evidence for such a combined 
role of cytokine and costimulatory adhesion molecule comes 
from preliminary data using similar type experiments with 
LFA-3 and ICAM-1 costimulation of memory cells, but now 
in the presence of rlL-4 (100 U/ml). It is interesting to note 
that LFA-3 costimulation in the presence of rlL-4 failed  to 
produce any detectable IFN-3,, while the induction of IL-5 
was unaffected. In contrast, rlL-4 added to ICAM-1 costimu- 
lated memory cells only partially suppressed IFN-3, secretion 
(data not  shown).  Furthermore,  the presence of rlL-4 did 
correlate with a slight increase of CD60-positive cells (data 
not  shown). 
In conclusion, we present here data showing differential 
requirements for ICAM-1- and LFA-3-mediated costimulation 
of the naive and memory CD4 + T  cell subsets. Moreover, 
repeated costimulation with ICAM-1 or LFA-3 leads within 
the memory CD4 + T  cell population to reciprocal cytokine 
secretion patterns for the lumphokines  IL-5 and GM-CSF, 
and to differential cell surface expression of the CD60 an- 
tigen.  The combined results strongly indicate a regulatory 
role for the costimulatory adhesion pathways LFA-1/ICAM-1 
and  CD2/LFA-3  in  T  cell activation  and  differentiation/ 
maturation. 
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